FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2891626570> ?p ?o ?g. }

• W2891626570 endingPage "1018" @default.
• W2891626570 startingPage "1014" @default.
• W2891626570 abstract "Objective: To investigate the relationship of clinical response of Juvenile Idiopathic Arthritis (JIA) to etanercept (ETN) with ETN levels, and the presence of anti-drug antibodies to ETN (ADAb). Methods: Prospective study of JIA patients under 18 years old. Clinical and pharmacological data were collected at two visits. JIA clinical inactivity and activity were assessed according to the Wallace criteria and to the Juvenile Arthritis Disease Activity Score (JADAS). ETN and ADAb serum levels assessments were determined using ELISA-based assays. Results: 126 patients were enrolled. The median duration of ETN treatment at inclusion was 569 days (range 53–2340). ADAb were undetectable (<10 ng/ml) in 171/218 (78%) samples and were > 25 ng/mL in 2/218 samples. No significant relationship between ETN concentration and the clinical inactivity status and JIA activity was found using either univariate logistic regression or multiple logistic regression analysis, adjusted on one individual descriptors, time since diagnosis, time of sampling, use of corticosteroids or methotrexate and classification of JIA. No correlation was found between the remission status and the detection of ADAb. Conclusion: This study did not demonstrate any correlation between JIA activity and circulating ETN levels in a large population of patients with JIA previously treated with ETN for at least 1.5 months. As described for adults, our study confirms that ETN is marginally immunogenic in pediatric patients. These results do not support the clinical usefulness of a monitoring of ADAb or ETN concentrations for the management of this group of JIA patients if they fail to achieve clinical inactive disease." @default.
• W2891626570 created "2018-09-27" @default.
• W2891626570 creator A5012048977 @default.
• W2891626570 creator A5016638923 @default.
• W2891626570 creator A5022995595 @default.
• W2891626570 creator A5029114167 @default.
• W2891626570 creator A5031099399 @default.
• W2891626570 creator A5033331169 @default.
• W2891626570 creator A5036481508 @default.
• W2891626570 creator A5043853010 @default.
• W2891626570 creator A5046909004 @default.
• W2891626570 creator A5068488019 @default.
• W2891626570 creator A5072203280 @default.
• W2891626570 creator A5079738832 @default.
• W2891626570 creator A5088946190 @default.
• W2891626570 creator A5090434136 @default.
• W2891626570 date "2019-06-01" @default.
• W2891626570 modified "2023-10-12" @default.
• W2891626570 title "Etanercept concentration and immunogenicity do not influence the response to Etanercept in patients with juvenile idiopathic arthritis" @default.
• W2891626570 cites W1951724000 @default.
• W2891626570 cites W1965310244 @default.
• W2891626570 cites W2024148297 @default.
• W2891626570 cites W2078886781 @default.
• W2891626570 cites W2082100198 @default.
• W2891626570 cites W2104175901 @default.
• W2891626570 cites W2107543415 @default.
• W2891626570 cites W2109984821 @default.
• W2891626570 cites W2110732019 @default.
• W2891626570 cites W2139541503 @default.
• W2891626570 cites W2169856473 @default.
• W2891626570 cites W2169911848 @default.
• W2891626570 cites W2303171999 @default.
• W2891626570 cites W2312982528 @default.
• W2891626570 cites W839461317 @default.
• W2891626570 doi "https://doi.org/10.1016/j.semarthrit.2018.09.002" @default.
• W2891626570 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30396593" @default.
• W2891626570 hasPublicationYear "2019" @default.
• W2891626570 type Work @default.
• W2891626570 sameAs 2891626570 @default.
• W2891626570 citedByCount "7" @default.
• W2891626570 countsByYear W28916265702019 @default.
• W2891626570 countsByYear W28916265702020 @default.
• W2891626570 countsByYear W28916265702021 @default.
• W2891626570 countsByYear W28916265702022 @default.
• W2891626570 countsByYear W28916265702023 @default.
• W2891626570 crossrefType "journal-article" @default.
• W2891626570 hasAuthorship W2891626570A5012048977 @default.
• W2891626570 hasAuthorship W2891626570A5016638923 @default.
• W2891626570 hasAuthorship W2891626570A5022995595 @default.
• W2891626570 hasAuthorship W2891626570A5029114167 @default.
• W2891626570 hasAuthorship W2891626570A5031099399 @default.
• W2891626570 hasAuthorship W2891626570A5033331169 @default.
• W2891626570 hasAuthorship W2891626570A5036481508 @default.
• W2891626570 hasAuthorship W2891626570A5043853010 @default.
• W2891626570 hasAuthorship W2891626570A5046909004 @default.
• W2891626570 hasAuthorship W2891626570A5068488019 @default.
• W2891626570 hasAuthorship W2891626570A5072203280 @default.
• W2891626570 hasAuthorship W2891626570A5079738832 @default.
• W2891626570 hasAuthorship W2891626570A5088946190 @default.
• W2891626570 hasAuthorship W2891626570A5090434136 @default.
• W2891626570 hasBestOaLocation W28916265701 @default.
• W2891626570 hasConcept C115961737 @default.
• W2891626570 hasConcept C126322002 @default.
• W2891626570 hasConcept C151956035 @default.
• W2891626570 hasConcept C159654299 @default.
• W2891626570 hasConcept C203014093 @default.
• W2891626570 hasConcept C2777077863 @default.
• W2891626570 hasConcept C2777226972 @default.
• W2891626570 hasConcept C2777575956 @default.
• W2891626570 hasConcept C2780574019 @default.
• W2891626570 hasConcept C2780868878 @default.
• W2891626570 hasConcept C2781059491 @default.
• W2891626570 hasConcept C2908647359 @default.
• W2891626570 hasConcept C54355233 @default.
• W2891626570 hasConcept C71924100 @default.
• W2891626570 hasConcept C86803240 @default.
• W2891626570 hasConcept C90924648 @default.
• W2891626570 hasConcept C99454951 @default.
• W2891626570 hasConceptScore W2891626570C115961737 @default.
• W2891626570 hasConceptScore W2891626570C126322002 @default.
• W2891626570 hasConceptScore W2891626570C151956035 @default.
• W2891626570 hasConceptScore W2891626570C159654299 @default.
• W2891626570 hasConceptScore W2891626570C203014093 @default.
• W2891626570 hasConceptScore W2891626570C2777077863 @default.
• W2891626570 hasConceptScore W2891626570C2777226972 @default.
• W2891626570 hasConceptScore W2891626570C2777575956 @default.
• W2891626570 hasConceptScore W2891626570C2780574019 @default.
• W2891626570 hasConceptScore W2891626570C2780868878 @default.
• W2891626570 hasConceptScore W2891626570C2781059491 @default.
• W2891626570 hasConceptScore W2891626570C2908647359 @default.
• W2891626570 hasConceptScore W2891626570C54355233 @default.
• W2891626570 hasConceptScore W2891626570C71924100 @default.
• W2891626570 hasConceptScore W2891626570C86803240 @default.
• W2891626570 hasConceptScore W2891626570C90924648 @default.
• W2891626570 hasConceptScore W2891626570C99454951 @default.
• W2891626570 hasIssue "6" @default.
• W2891626570 hasLocation W28916265701 @default.
• W2891626570 hasLocation W28916265702 @default.

• next